Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Contact-Force Guided Hybrid-Dual-Energy Ultra-Saline-Irrigated Ablation First-in-Man for Ventricular Arrhythmia: CHU VA

NCT07503769 is registered in ClinicalTrials.gov with Shanghai MicroPort EP MedTech Co., Ltd. as lead sponsor.

NCT NCT07503769
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07503769 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Contact-Force Guided Hybrid-Dual-Energy Ultra-Saline-Irrigated Ablation First-in-Man for Ventricular Arrhythmia: CHU VA
Lead sponsor
Shanghai MicroPort EP MedTech Co., Ltd.
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
February 3, 2026
Completion date
October 31, 2026
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

premature ventricular contractions, ventricular tachycardia